| scholarly article | Q13442814 |
| P50 | author | Delmar M Lourenço | Q79886772 |
| P2093 | author name string | Stephen J Marx | |
| P2860 | cites work | The same pocket in menin binds both MLL and JUND but has opposite effects on transcription | Q27677227 |
| Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors. | Q51420518 | ||
| Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. | Q52142743 | ||
| MEN4 and CDKN1B mutations: the latest of the MEN syndromes. | Q53103786 | ||
| Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure. | Q53287210 | ||
| Polyclonality of Parathyroid Tumors in Neonatal Severe Hyperparathyroidism. | Q53562178 | ||
| A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome. | Q54353310 | ||
| Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy | Q69858364 | ||
| Clinical studies of multiple endocrine neoplasia type 1 (MEN1) | Q71777163 | ||
| Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1) | Q85675298 | ||
| MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines | Q86546147 | ||
| Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis | Q28078843 | ||
| Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1 | Q28257084 | ||
| Positional cloning of the gene for multiple endocrine neoplasia-type 1 | Q28307577 | ||
| Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop | Q33570129 | ||
| Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism | Q33879558 | ||
| Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). | Q34283436 | ||
| PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy | Q34284783 | ||
| Technical report: Ethical and policy issues in genetic testing and screening of children | Q34328987 | ||
| Preimplantation Genetic Diagnosis: Prenatal Testing for Embryos Finally Achieving Its Potential | Q35667220 | ||
| Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism | Q35789261 | ||
| Early Onset Primary Hyperparathyroidism Associated with a Novel Germline Mutation in CDKN1B. | Q35894421 | ||
| Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1. | Q35897668 | ||
| MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients | Q36192096 | ||
| The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations | Q36735215 | ||
| Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance | Q36949646 | ||
| Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states | Q37198026 | ||
| Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1. | Q37408028 | ||
| Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life. | Q38157760 | ||
| Calcimimetic and Calcilytic Drugs: Feats, Flops, and Futures | Q38576402 | ||
| Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years. | Q38696748 | ||
| Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature | Q38841484 | ||
| Management impact: effects on quality of life and prognosis in MEN1. | Q39451392 | ||
| Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. | Q40661619 | ||
| Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas. | Q43627806 | ||
| Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. | Q43819872 | ||
| Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1. | Q47422220 | ||
| The future: genetics advances in MEN1 therapeutic approaches and management strategies. | Q47814736 | ||
| Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue | Q50025155 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | multiple endocrine neoplasia | Q1553018 |
| multiple endocrine neoplasia type 1 | Q3347154 | ||
| P304 | page(s) | 359 | |
| P577 | publication date | 2018-07-17 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Questions and Controversies About Parathyroid Pathophysiology in Children With Multiple Endocrine Neoplasia Type 1 | |
| P478 | volume | 9 |
| Q64120689 | Could the Less-Than Subtotal Parathyroidectomy Be an Option for Treating Young Patients With Multiple Endocrine Neoplasia Type 1-Related Hyperparathyroidism? | cites work | P2860 |
Search more.